Physician profile
Shoshanah E Kahn
NPI 1518944743
$6,038.15
in general payments reported to CMS, 2019-2025
31 companies · $880 in 2025
The $880 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $620 · 2021: $911 · 2022: $721 · 2023: $894 · 2024: $928 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,702.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $803.33 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $684.55 | 2019-2025 | Farxiga, Lokelma |
| Merck Sharp & Dohme LLC | $574.61 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $531.01 | 2019-2024 | Xarelto |
| Amgen INC. | $429.04 | 2019-2023 | Repatha |
| Medtronic Vascular, INC. | $374.30 | 2019-2020 | |
| Esperion Therapeutics, INC. | $372.01 | 2020-2025 | Nexletol |
| Pfizer INC. | $225.06 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $198.30 | 2019-2024 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $193.17 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.93 | 2021-2024 | Jardiance |
| Amarin Pharma, INC. | $161.04 | 2020-2021 | |
| Philips North America LLC | $145.30 | 2022-2025 | Mcot, (Ck4) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.45 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $118.78 | 2020-2025 | Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $103.35 | 2021-2023 | Mycarelink |
| Medicomp INC | $95.34 | 2025 | Telepatch Cardiac Monitor |
| Impulse Dynamics (USA) INC. | $93.38 | 2023 | Optimizer |
| Scpharmaceuticals INC. | $87.11 | 2025 | |
| Alnylam Pharmaceuticals INC. | $79.12 | 2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $75.70 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.47 | 2024-2025 | |
| Edwards Lifesciences Corporation | $58.33 | 2022-2023 | Sapien 3 Ultra Resilia |
| Kestra Medical Technology Services, INC. | $58.11 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $50.47 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $46.85 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $33.81 | 2023 | Inpefa |
| Abbott Laboratories | $24.94 | 2024 | Aveir |
| Abiomed | $22.81 | 2025 | |
| Akcea Therapeutics, INC. | $19.80 | 2020 | |
| Lundbeck LLC | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoshanah Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.